In the Indian medical devices industry, there were 4 M&A deals announced in Q4 2023, worth a total value of $57.8m, according to GlobalData’s Deals Database. The $44m acquisition of Biocon Biologics by Eris Lifesciences was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
Smarter leaders trust GlobalData
In value terms, M&A activity in India increased by 738% in Q4 2023 compared with the previous quarter’s total of $6.9m. Related deal volume increased by 33% in Q4 2023 versus the previous quarter.
The top-ranked financial advisors supporting these M&A deals in India in Q4 2023 were Wodehouse Capital Advisors Private; IMAP; Mirae Asset Securities with 2, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In 2023 – Thematic Intelligence, buy the report here.
See Also:
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.
